MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Share Price Hits Fresh 52-Week High
- August 19, 2026
- Posted by: Harsh Piplani
- Category: News
MANIPAL HEALTH ENTERPRI L Share Price rose 1.7% to Rs 738.2 and touched a fresh 52-week high of Rs 743.2. The Healthcare stock now carries a market capitalisation of Rs 94,930.77 crore.
MANIPAL HEALTH ENTERPRI L Share Price is at Rs 738.2 today, up Rs 12.35 or 1.7% from the previous close of Rs 725.85, after the stock touched a fresh 52-week high of Rs 743.2. The company’s market capitalisation stands at Rs 94,930.77 crore, placing it among the larger counters in the Healthcare space being tracked in today’s market update.
The verified data confirms the price event clearly: the stock opened at Rs 728.05, traded between Rs 720 and Rs 743.2, and moved to a new one-year high during the session. Turnover stood at Rs 5.09 crore with current volume of 68,966 shares. For investors searching MANIPAL HEALTH ENTERPRI L Share Price Today or MANIPAL HEALTH ENTERPRI L Stock News, the immediate takeaway is that the stock has entered a fresh yearly high zone on a positive day move.
What the supplied data does not establish is a company-specific trigger. So, while the move is relevant because a new 52-week peak often attracts fresh market attention, the available figures support the price breakout itself rather than a verified catalyst. Univest notes that the combination of a higher price, fresh one-year high and sizeable market capitalisation is enough to put the stock on the radar of investors tracking 52 Week High Stocks, Market Movers and Stock Updates in the Indian Stock Market.
MANIPAL HEALTH ENTERPRI L Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 738.2 |
| Previous Close | Rs 725.85 |
| Today's Change | +Rs 12.35 (+1.7%) |
| Day Open | Rs 728.05 |
| Fresh 52-Week High | Rs 743.2 |
| Day Low | Rs 720 |
| Current Volume | 68,966 |
| Turnover | Rs 5.09 crore |
| Market Capitalisation | Rs 94,930.77 crore |
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) traded at Rs 738.2. versus the previous close of Rs 725.85, a rise of 1.7%. The stock opened at Rs 728.05, reached Rs 743.2, touched Rs 720. Reported volume was 68,966.
MANIPAL HEALTH ENTERPRI L Share Price Today reflects a session in which buyers kept the stock above its previous close and pushed it to a fresh 52-week high of Rs 743.2. The stock opened at Rs 728.05, fell as low as Rs 720, and then traded higher, showing an intraday range of Rs 23.2.
From the previous close of Rs 725.85 to the current price of Rs 738.2, the stock added Rs 12.35, equivalent to a 1.7% rise. That day change matters because it was accompanied by a move to a new yearly high, not just a routine advance. The day’s high of Rs 743.2 now marks the latest 52-week peak, while the stock remained close to that zone at the time of the event.
Volume participation also deserves attention. Current volume stood at 68,966 shares and turnover was Rs 5.09 crore. Even without a longer average-volume comparison in the supplied data, the turnover figure confirms active traded value around the breakout session. For traders following Price Action and for longer-term investors scanning MANIPAL HEALTH ENTERPRI L Share News, the market is clearly responding to the stock at elevated levels.
The structure of the session also shows that the stock did not simply gap to the top and stay flat. Instead, it opened above the previous close, tested Rs 720 on the downside and still moved up to Rs 743.2, indicating sustained buying interest across the day’s range. That is why MANIPAL HEALTH ENTERPRI L Share Price has become part of today’s Stocks in News conversation. The next step is to place this move in the context of valuation and business quality rather than price alone.
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 94,930.77 crore |
| P/E Ratio | 51.17x |
| P/B Ratio | 2.03x |
| ROE | -0.78% |
| ROCE | 8.31% |
MANIPAL HEALTH ENTERPRI L was valued at a P/E ratio of 51.17x, a P/B ratio of 2.03x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.
Profitability and capital efficiency were represented by ROE of -0.78% and ROCE of 8.31%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Benchmark Scope | same sector |
| Company P/E Ratio | 51.17x |
| Benchmark Median P/E | 20.79x |
| Benchmark Average P/E | 47.16x |
| Benchmark P/E Range | 0x to 1,635.98x |
| Company P/B Ratio | 2.03x |
| Benchmark Median P/B | 1.9x |
| Company ROE | -0.78% |
| Benchmark Median ROE | 11.09% |
| Company ROCE | 8.31% |
| Benchmark Median ROCE | 13.29% |
| Company Market Capitalisation | Rs 94,930.77 crore |
| Benchmark Median Market Cap | Rs 134.22 crore |
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) is classified under sector: Healthcare.
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 51.17x, which is above the benchmark median of 20.79x, a difference of +146.13%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROE of -0.78%, which is below the benchmark median of 11.09%, a difference of -107.03%. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a ROCE of 8.31%, which is below the benchmark median of 13.29%, a difference of -37.47%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Ind-Swift Laboratories Ltd. | INDSWFTLAB | 2,724.51 | 51.17 | 2.03 | -0.78 | 8.31 |
| Beta Drugs Ltd. | BETA | 2,697.08 | 62.93 | 9.96 | 18.65 | 22.17 |
| Dr Agarwals Eye Hospital Ltd. | DRAGARWQ | 2,583.65 | 33.9 | 6.99 | 36.29 | 42.4 |
| Sai Parenteral's Ltd. | SAIPARENT | 2,431.62 | 167.79 | 3.07 | 13.9 | 12.97 |
| Fredun Pharmaceuticals Ltd. | FREDUN | 2,403.56 | 54.45 | 8.13 | 11.42 | 13.15 |
MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a P/E ratio of 51.17x compared with the displayed peer median of 54.45x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of -0.78% compares with a peer median of 13.9% across the companies shown in the table. ROCE stood at 8.31% versus the displayed peer median of 13.15%, providing a capital-efficiency comparison. MANIPAL HEALTH ENTERPRI L (MANIPALHOS) has a market capitalisation of Rs 94,930.77 crore. Among the 5 peers shown, 0 have a larger market capitalisation.
Why Investors Are Watching MANIPAL HEALTH ENTERPRI L
The stock is attracting attention because a verified price event has emerged alongside a distinctive valuation and sector profile. Key points investors are watching include:
- Fresh 52-week high: the stock touched Rs 743.2 and was trading at Rs 738.2, up 1.7% on the day.
- Clear day move: it rose Rs 12.35 from the previous close of Rs 725.85 after opening at Rs 728.05 and moving within Rs 720 to Rs 743.2.
- Active trading value: turnover stood at Rs 5.09 crore with volume of 68,966 shares.
- Large listed size: market capitalisation is Rs 94,930.77 crore, far above the supplied sector median and average.
- Mixed fundamentals: P/E is 51.17, P/B is 2.03, ROE is -0.78 and ROCE is 8.31.
- Sector positioning: the Healthcare benchmark covers 196 companies, giving investors a broad context for valuation and return comparisons.
About MANIPAL HEALTH ENTERPRI L
MANIPAL HEALTH ENTERPRI L is classified within the Healthcare sector in the supplied dataset. The peer list places it in a comparison set that includes hospital and healthcare services as well as pharmaceuticals and drugs companies, which means investors often assess it within the broader listed Healthcare universe rather than through price movement alone.
From a market perspective, the company stands out for its scale. Its market capitalisation of Rs 94,930.77 crore is much larger than the market caps shown for the supplied peers and also much larger than the median and average values in the same-sector benchmark. That makes MANIPAL HEALTH ENTERPRI L Share Price relevant not only to stock-specific screens but also to broader market-watch lists focused on large-cap Healthcare names, 52 Week High Stocks and daily Stock News.
Because the supplied company-description fields are limited, the most verifiable business context here is its sector placement and how the market is valuing it relative to Healthcare benchmarks and peers. On Univest, that makes the stock a useful case study in how price strength, sector standing and relative valuation can all interact even when return ratios remain mixed.
Track MANIPAL HEALTH ENTERPRI L Share Price on Univest
Use MANIPAL HEALTH ENTERPRI L (MANIPALHOS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Investors tracking MANIPAL HEALTH ENTERPRI L Share Price can use Univest to follow live share price movement, 52-week levels, market capitalisation, valuation ratios, peer comparison and broader market insights in one place. For users searching MANIPAL HEALTH ENTERPRI L Share Price Live, MANIPAL HEALTH ENTERPRI L NSE, MANIPAL HEALTH ENTERPRI L BSE or MANIPAL HEALTH ENTERPRI L Shareholding Pattern, Univest helps organise the verified market data around the stock’s latest price event.
As MANIPAL HEALTH ENTERPRI L Share Price remains near its fresh one-year high, investors may want to monitor whether the stock sustains activity near Rs 743.2, how valuation compares with the Healthcare benchmark over time, and whether profitability metrics such as ROE and ROCE improve relative to peers. Univest presents these data points in a format designed for ongoing tracking rather than one-day observation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is the latest MANIPAL HEALTH ENTERPRI L Share Price Today?
Ans. MANIPAL HEALTH ENTERPRI L Share Price Today is Rs 738.2. The stock was up Rs 12.35, or 1.7%, from the previous close of Rs 725.85, and it touched a fresh 52-week high of Rs 743.2 during the session.
Why is MANIPAL HEALTH ENTERPRI L in focus today?
Ans. The stock is in focus because it hit a fresh one-year high of Rs 743.2 on 19 August 2026. At the time of the event, it was trading at Rs 738.2 with a 1.7% gain and Rs 5.09 crore turnover.
What was the day range for MANIPAL HEALTH ENTERPRI L shares?
Ans. The stock opened at Rs 728.05, moved to a day low of Rs 720 and climbed to a day high of Rs 743.2. That intraday range shows the stock stayed active before reaching its fresh 52-week peak.
What is the 52-week high of MANIPAL HEALTH ENTERPRI L?
Ans. The fresh 52-week high is Rs 743.2. The stock was trading at Rs 738.2 when this update was captured, meaning it remained close to the yearly high after rising 1.7% from the previous close of Rs 725.85.
What is the market capitalisation of MANIPAL HEALTH ENTERPRI L?
Ans. MANIPAL HEALTH ENTERPRI L has a market capitalisation of Rs 94,930.77 crore. In the supplied Healthcare benchmark, the sector median market cap is Rs 134.22 crore and the average is Rs 465.93 crore, highlighting the company’s far larger scale.
How is MANIPAL HEALTH ENTERPRI L valued on P/E and P/B?
Ans. The stock trades at a P/E ratio of 51.17 and a P/B ratio of 2.03. In the supplied Healthcare benchmark, the median P/E is 20.79 and median P/B is 1.9, placing earnings valuation above the sector midpoint.
How do ROE and ROCE compare for MANIPAL HEALTH ENTERPRI L?
Ans. MANIPAL HEALTH ENTERPRI L has ROE of -0.78 and ROCE of 8.31. In comparison, the Healthcare benchmark median ROE is 11.09 and median ROCE is 13.29, so the supplied return ratios are below sector median levels.
How does MANIPAL HEALTH ENTERPRI L compare with the supplied peers?
Ans. Its market cap of Rs 94,930.77 crore is far above peers such as Beta Drugs, Dr Agarwals Eye Hospital and Fredun Pharmaceuticals, each near Rs 2,400 crore to Rs 2,700 crore. Profitability ratios, however, are lower than several supplied peers.
What sector does MANIPAL HEALTH ENTERPRI L belong to?
Ans. The company belongs to the Healthcare sector. The supplied sector snapshot covers 196 same-sector companies, giving investors benchmark data on valuation, return ratios and market-cap ranges while assessing the stock’s fresh 52-week high.
What should investors monitor after this fresh 52-week high?
Ans. Investors can monitor whether the stock sustains trade near Rs 743.2, how turnover and volume evolve from the current 68,966 shares and Rs 5.09 crore, and how valuation plus return ratios compare with Healthcare sector benchmarks.
